EUVIMEDEUVIMED entdecken
Crossref

Deflux and Botulinum Toxin Type A as Combined Therapeutic Approach in Pediatric Vesicoureteral Reflux and Concurrent Non‐Neurogenic Dysfunctional Voiding: Insights From a Prospective Single‐Arm Study

Negar Mohammadi Ganjaroudi iD, Negin Jarrah iD, Parmida Sadat Pezeshki iD, Shervin Tavakoli iD, Abdol-Mohammad Kajbafzadeh iD

Neurourology and Urodynamics · 02.11.2026

DOI: 10.1002/nau.70528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurourology and Urodynamics, online erschienen am 02.11.2026. Verfasst von Negar Mohammadi Ganjaroudi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Urology and Regenerative Medicine Research Center, Gene, Cell and Tissue Research Institute, Children's Medical Center, Tehran University o…. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Tehran University of Medical Sciences, Tehran University of Medical Sciences and Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We aimed to assess uroflowmetric measurements and quality‐of‐life outcomes following synchronous Deflux injection and pelvic floor and inter‐sphincteric Botulinum toxin type A (BTX‐A) injection in pediatric patients diagnosed with vesicoureteral reflux (VUR) and non‐neurogenic dysfunctional voiding (NNDV) at 6‐month and 1‐year follow‐ups.

Methods

This prospective study included female children aged 5–18 years with concurrent VUR and NNDV. All participants underwent pre‐and postoperative ultrasonography, uroflowmetry study and quality‐of‐life assessment. Deflux injection was performed using the hydrodistension implantation technique in the refluxing ureter. BTX‐A injection was administered to the periurethral and perineal body areas. Participants with functional constipation, confirmed by ROME Ⅳ criteria, received perianal BTX‐A injection. All statistical analyses were conducted using R Statistical software (version 4.4.2), with a significance threshold set at p < 0.05.

Results

Among 30 patients, near bell‐shaped voiding patterns were observed in 23 (76.7%) at 6‐month and 27 (90%) at 1‐year follow‐ups with a significant overall change across three assessment timepoints (LR = 37.47, p < 0.001). Complete VUR resolution was observed in 40 of 46 (87%) refluxing renal units at 6 months ( p < 0.001). Volume‐adjusted maximal and average flow indices improved significantly over time ( p = 0.003 and p < 0.001, respectively). PinQ scores decreased from 20.83 ± 8.55 preoperatively to 11.26 ± 6.91 at 1‐year follow‐up ( p < 0.001).

Conclusion

This prospective study indicated that the combined BTX‐A and Deflux injections were associated with improvements in dysfunctional voiding severity, voiding flow parameters, voiding diaries, and quality‐of‐life outcomes in children with concurrent NNDV and VUR.

Schlagwörter

Stichwörter der Autor:innen

botulinum toxins, type Aquality of lifeurinary incontinenceurinary tract infectionsurination disordersvesicoureteral reflux

Autor:innen und Institutionen

  • Pediatric Urology and Regenerative Medicine Research Center, Gene, Cell and Tissue Research Institute, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Negar Mohammadi Ganjaroudi, Negin Jarrah, Parmida Sadat Pezeshki, Shervin Tavakoli, Abdol-Mohammad Kajbafzadeh

Förderung

  • Tehran University of Medical Sciences
  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Ganjaroudi, N. M., Jarrah, N., Pezeshki, P. S., Tavakoli, S., & Kajbafzadeh, A. M. (2026). Deflux and Botulinum Toxin Type A as Combined Therapeutic Approach in Pediatric Vesicoureteral Reflux and Concurrent Non‐Neurogenic Dysfunctional Voiding: Insights From a Prospective Single‐Arm Study. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70528

Vancouver

Ganjaroudi NM, Jarrah N, Pezeshki PS, Tavakoli S, Kajbafzadeh AM. Deflux and Botulinum Toxin Type A as Combined Therapeutic Approach in Pediatric Vesicoureteral Reflux and Concurrent Non‐Neurogenic Dysfunctional Voiding: Insights From a Prospective Single‐Arm Study. Neurourology and Urodynamics. 2026. doi:10.1002/nau.70528

BibTeX
@article{Ganjaroudi2026,
  author = {Ganjaroudi, Negar Mohammadi and Jarrah, Negin and Pezeshki, Parmida Sadat and Tavakoli, Shervin and Kajbafzadeh, Abdol-Mohammad},
  title = {Deflux and Botulinum Toxin Type A as Combined Therapeutic Approach in Pediatric Vesicoureteral Reflux and Concurrent Non‐Neurogenic Dysfunctional Voiding: Insights From a Prospective Single‐Arm Study},
  journal = {Neurourology and Urodynamics},
  year = {2026},
  doi = {10.1002/nau.70528}
}
Kostenlos starten →